IPMSX
Price
$19.93
Change
+$0.06 (+0.30%)
Updated
Oct 17 closing price
Net Assets
731.86M
VIMAX
Price
$358.27
Change
+$0.63 (+0.18%)
Updated
Oct 17 closing price
Net Assets
201.28B
Interact to see
Advertisement

IPMSX vs VIMAX

Header iconIPMSX vs VIMAX Comparison
Open Charts IPMSX vs VIMAXBanner chart's image
Voya Index Plus MidCap Port S
Price$19.93
Change+$0.06 (+0.30%)
VolumeN/A
Net Assets731.86M
Vanguard Mid Cap Index Admiral
Price$358.27
Change+$0.63 (+0.18%)
VolumeN/A
Net Assets201.28B
IPMSX vs VIMAX Comparison Chart in %
View a ticker or compare two or three
VS
IPMSX vs. VIMAX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPMSX is a Buy and VIMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 201B vs. IPMSX (732M). VIMAX pays higher dividends than IPMSX: VIMAX (1.48) vs IPMSX (0.40). IPMSX was incepted earlier than VIMAX: IPMSX (24 years) vs VIMAX (24 years). IPMSX (0.91) is less costly to investors than VIMAX (0.05). IPMSX is a more actively managed with annual turnover of: 60.00 vs. VIMAX (16.00). IPMSX has a lower initial minimum investment than VIMAX: IPMSX (0) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 7.58 vs. IPMSX (-5.17). VIMAX return over 5 years is better than : 57.32 vs. IPMSX (16.54).
IPMSXVIMAXIPMSX / VIMAX
Total Expense Ratio0.850.051,700%
Annual Report Gross Expense Ratio0.910.051,820%
Fund Existence24 years24 years-
Gain YTD-3.6649.707-38%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets732M201B0%
Annual Yield % from dividends0.401.4827%
Returns for 1 year-5.177.58-68%
Returns for 3 years25.5349.7051%
Returns for 5 years16.5457.3229%
Returns for 10 years3.25140.932%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVX1.980.02
+1.02%
NOVONIX Limited
CXM7.620.05
+0.66%
Sprinklr
ATIIU10.59N/A
N/A
Archimedes Tech SPAC Partners II Co
ABVC2.92N/A
N/A
ABVC BioPharma
MDGL438.90-3.23
-0.73%
Madrigal Pharmaceuticals